Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 08 Mar 2023
3-year results show that patients who underwent low-risk aortic valve replacement continue to report lower rates of all-cause mortality and stroke with TAVI compared to surgery
Read Full NewsA phase 2a trial showed that NLX-112 was safe and well tolerated in patients with Parkinson disease, while also reducing levodopa-induced dyskinesia and motor symptoms, supporting further clinical development.
AskBio noted that AB-1009 also recently received fast track and orphan drug designations from the FDA.
Amlitelimab Effective, Safe for Atopic Dermatitis in Patients 12 Years and Older
1.
Healthcare in the Mix in President Biden's Farewell Address
2.
A researcher has found that yoga exhibits the "most improvement" in helping long-term cancer survivors restore their brain health.
3.
Analysis of NRG trial in limited-stage small cell lung cancer suggests QOL benefit with twice- vs. once-daily radiation
4.
Many Americans unaware of links between HPV and cancers, poll reveals
5.
Ineffective medication can remove the "worst fear" of schizophrenia.
1.
Unveiling Tumor Immunity: Pan-Cancer Proteogenomics Characterization
2.
Managing High Potassium Levels: A Comprehensive Guide to Veltassa
3.
Can Wearables and AI Become a Gamechanger for Histiocytic Cancer Detection?
4.
Unlocking the Mystery of Methaemoglobinaemia: A New Hope for Treatment
5.
Cancer Staging: Updates, Clinical Insights, and Educational Resources for Medical Professionals
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion
2.
Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC
3.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
4.
First-Line Maintenance Therapy for Metastatic Urothelial Carcinoma: Bridging Clinical Practice and Trials
5.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge